SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001213900-24-082151 from Zhengye Biotechnology Holding Ltd (ZYBT)

Zhengye Biotechnology Holding Ltd
Date: Sept. 26, 2024 · CIK: 0001975641 · Accession: 0001213900-24-082151

AI Filing Summary & Sentiment

File numbers found in text: 333-276436

Date
September 26, 2024
Author
Kingswood Capital Partners, LLC
Form
CORRESP
Company
Zhengye Biotechnology Holding Ltd

Letter

Via EDGAR Division of Corporation Finance Office of Life Sciences Attention: Franklin Wyman Re: Zhengye Biotechnology Holding Limited Registration Statement on Form F-1, as amended Initially Filed on January 9, 2024 File No. 333-276436

Dear Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, Kingswood Capital Partners, LLC, as the underwriter, hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 4:30 p.m., Eastern Time, on Monday, September 30, 2024, or as soon thereafter as practicable.

Pursuant to Rule 460 under the Act, we wish to advise you that we have distributed as many copies of the Preliminary Prospectus dated June 14, 2024, to selected dealers, institutions and others as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

We have been advised by the prospective underwriters that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

Very truly yours,
Kingswood Capital Partners, LLC

Show Raw Text
CORRESP
1
filename1.htm

Kingswood Capital Partners, LLC

126 E 56th St, 22nd Floor,

New York, NY 10022

As a representative of the prospective
underwriters

Via EDGAR

September 26, 2024

Division of Corporation Finance

Office of Life Sciences

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, D.C., 20549

    Attention:
    Franklin Wyman

    Daniel Gordon

    Doris Stacey Gama

    Jason Drory

    Re:
    Zhengye Biotechnology Holding Limited

    Registration Statement on Form F-1, as amended

    Initially Filed on January 9, 2024

    File No. 333-276436

Dear Ladies and Gentlemen:

Pursuant to
Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, Kingswood Capital Partners, LLC, as the underwriter, hereby requests acceleration of the
effective date of the above-referenced Registration Statement so that it will become effective at 4:30 p.m.,
Eastern Time, on Monday, September 30, 2024, or as soon thereafter as practicable.

Pursuant to
Rule 460 under the Act, we wish to advise you that we have distributed as many copies of the Preliminary Prospectus dated June 14, 2024,
to selected dealers, institutions and others as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

We have been advised
by the prospective underwriters that they have complied and will continue to comply with the requirements of Rule 15c2-8 under
the Securities Exchange Act of 1934, as amended.

Very truly yours,

    Kingswood Capital Partners, LLC

    By:

    /s/ Tony Tian

    Name:
    Tony Tian

    Title:
    Senior Managing Director